Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 280

1.

Effect of concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention.

Banerjee S, Weideman RA, Weideman MW, Little BB, Kelly KC, Gunter JT, Tortorice KL, Shank M, Cryer B, Reilly RF, Rao SV, Kastrati A, de Lemos JA, Brilakis ES, Bhatt DL.

Am J Cardiol. 2011 Mar 15;107(6):871-8. doi: 10.1016/j.amjcard.2010.10.073. Epub 2011 Jan 19.

PMID:
21247527
2.

Risk of adverse clinical outcomes with concomitant use of clopidogrel and proton pump inhibitors following percutaneous coronary intervention.

Gupta E, Bansal D, Sotos J, Olden K.

Dig Dis Sci. 2010 Jul;55(7):1964-8. doi: 10.1007/s10620-009-0960-8.

PMID:
19731021
3.

Impact of concomitant treatment with proton pump inhibitors and clopidogrel on clinical outcome in patients after coronary stent implantation.

Tentzeris I, Jarai R, Farhan S, Brozovic I, Smetana P, Geppert A, Wojta J, Siller-Matula J, Huber K.

Thromb Haemost. 2010 Dec;104(6):1211-8. doi: 10.1160/TH10-04-0218. Epub 2010 Oct 12.

PMID:
20941464
4.

Relation of proton pump inhibitor use after percutaneous coronary intervention with drug-eluting stents to outcomes.

Gaglia MA Jr, Torguson R, Hanna N, Gonzalez MA, Collins SD, Syed AI, Ben-Dor I, Maluenda G, Delhaye C, Wakabayashi K, Xue Z, Suddath WO, Kent KM, Satler LF, Pichard AD, Waksman R.

Am J Cardiol. 2010 Mar 15;105(6):833-8. doi: 10.1016/j.amjcard.2009.10.063.

PMID:
20211327
5.

Concomitant use of clopidogrel and proton pump inhibitors is not associated with major adverse cardiovascular events following coronary stent implantation.

Schmidt M, Johansen MB, Robertson DJ, Maeng M, Kaltoft A, Jensen LO, Tilsted HH, Bøtker HE, Sørensen HT, Baron JA.

Aliment Pharmacol Ther. 2012 Jan;35(1):165-74. doi: 10.1111/j.1365-2036.2011.04890.x. Epub 2011 Nov 4.

6.

Effect of proton pump inhibitors on clinical outcome in patients treated with clopidogrel: a systematic review and meta-analysis.

Siller-Matula JM, Jilma B, Schrör K, Christ G, Huber K.

J Thromb Haemost. 2010 Dec;8(12):2624-41. doi: 10.1111/j.1538-7836.2010.04049.x. Review.

7.

Risk of drug-eluting stent thrombosis in patients receiving proton pump inhibitors.

Sarafoff N, Sibbing D, Sonntag U, Ellert J, Schulz S, Byrne RA, Mehilli J, Schömig A, Kastrati A.

Thromb Haemost. 2010 Sep;104(3):626-32. doi: 10.1160/TH09-11-0800. Epub 2010 Jul 20.

PMID:
20664905
8.

Effect of individual proton pump inhibitors on cardiovascular events in patients treated with clopidogrel following coronary stenting: results from the Ibaraki Cardiac Assessment Study Registry.

Aihara H, Sato A, Takeyasu N, Nishina H, Hoshi T, Akiyama D, Kakefuda Y, Watabe H, Aonuma K; ICAS Registry Investigators..

Catheter Cardiovasc Interv. 2012 Oct 1;80(4):556-63. doi: 10.1002/ccd.23327. Epub 2012 Jan 10.

PMID:
22234956
9.

Combined clopidogrel and proton pump inhibitor therapy is associated with higher cardiovascular event rates after percutaneous coronary intervention: a report from the BASKET trial.

Burkard T, Kaiser CA, Brunner-La Rocca H, Osswald S, Pfisterer ME, Jeger RV; BASKET Investigators..

J Intern Med. 2012 Mar;271(3):257-63. doi: 10.1111/j.1365-2796.2011.02423.x. Epub 2011 Aug 11.

10.

Effect of comedication with proton pump inhibitors (PPIs) on post-interventional residual platelet aggregation in patients undergoing coronary stenting treated by dual antiplatelet therapy.

Zuern CS, Geisler T, Lutilsky N, Winter S, Schwab M, Gawaz M.

Thromb Res. 2010 Feb;125(2):e51-4. doi: 10.1016/j.thromres.2009.08.016. Epub 2009 Sep 24.

PMID:
19781742
11.

Major adverse cardiac events among postpercutaneous coronary intervention patients on clopidogrel and proton pump inhibitors.

Ching GG, Li D, Baker WL, Hohl PK, Mather JF, McKay RG, Lundbye JB.

Conn Med. 2012 Apr;76(4):205-11.

PMID:
22611719
12.

A comparison of aspirin and clopidogrel with or without proton pump inhibitors for the secondary prevention of cardiovascular events in patients at high risk for gastrointestinal bleeding.

Hsiao FY, Tsai YW, Huang WF, Wen YW, Chen PF, Chang PY, Kuo KN.

Clin Ther. 2009 Sep;31(9):2038-47. doi: 10.1016/j.clinthera.2009.09.005.

PMID:
19843493
13.

Clinical outcomes in patients with the concomitant use of clopidogrel and proton pump inhibitors after percutaneous coronary intervention: an analysis from the Guthrie Health Off-Label Stent (GHOST) investigators.

Harjai KJ, Shenoy C, Orshaw P, Usmani S, Boura J, Mehta RH.

Circ Cardiovasc Interv. 2011 Apr 1;4(2):162-70. doi: 10.1161/CIRCINTERVENTIONS.110.958884. Epub 2011 Mar 8.

14.

Risk of rehospitalization for patients using clopidogrel with a proton pump inhibitor.

Stockl KM, Le L, Zakharyan A, Harada AS, Solow BK, Addiego JE, Ramsey S.

Arch Intern Med. 2010 Apr 26;170(8):704-10. doi: 10.1001/archinternmed.2010.34.

PMID:
20421557
15.

Risk of adverse outcomes in Taiwan associated with concomitant use of clopidogrel and proton pump inhibitors in patients who received percutaneous coronary intervention.

Huang CC, Chen YC, Leu HB, Chen TJ, Lin SJ, Chan WL, Chen JW.

Am J Cardiol. 2010 Jun 15;105(12):1705-9. doi: 10.1016/j.amjcard.2010.01.348. Epub 2010 Apr 27.

PMID:
20538118
16.

One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study.

Ortolani P, Marino M, Marzocchi A, De Palma R, Branzi A.

J Cardiovasc Med (Hagerstown). 2012 Dec;13(12):783-9. doi: 10.2459/JCM.0b013e3283416b6b.

PMID:
21252697
17.

Comparison of 600 versus 300-mg Clopidogrel loading dose in patients with ST-segment elevation myocardial infarction undergoing primary coronary angioplasty.

Mangiacapra F, Muller O, Ntalianis A, Trana C, Heyndrickx GR, Bartunek J, Vanderheyden M, Wijns W, De Bruyne B, Barbato E.

Am J Cardiol. 2010 Nov 1;106(9):1208-11. doi: 10.1016/j.amjcard.2010.06.044.

PMID:
21029814
18.

A population-based study of the drug interaction between proton pump inhibitors and clopidogrel.

Juurlink DN, Gomes T, Ko DT, Szmitko PE, Austin PC, Tu JV, Henry DA, Kopp A, Mamdani MM.

CMAJ. 2009 Mar 31;180(7):713-8. doi: 10.1503/cmaj.082001. Epub 2009 Jan 28.

19.

Cardiovascular risk in clopidogrel-treated patients according to cytochrome P450 2C19*2 loss-of-function allele or proton pump inhibitor coadministration: a systematic meta-analysis.

Hulot JS, Collet JP, Silvain J, Pena A, Bellemain-Appaix A, Barthélémy O, Cayla G, Beygui F, Montalescot G.

J Am Coll Cardiol. 2010 Jul 6;56(2):134-43. doi: 10.1016/j.jacc.2009.12.071.

20.

Supplemental Content

Support Center